(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE

ST13

US500000090847595

Class

5

Filing

90847595

Registration

7219384

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

11/14/2023

Trademark type

Combined

Nice classes

5

Filing date

07/26/2021

Registration date

11/14/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/14/2023

Last transaction

11/14/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2011-00-00

First use in commerce

2011-00-00

Drawing code

3

Owner type

99

Owner location

La Roche-Posay, FR

Examiner

MUNN LEWIS, LAKEISHA S

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a rectangle above the term LA ROCHE-POSAY which is stacked above the term LABORATOIRE DERMATOLOGIQUE.

Holders and representatives

Holders

L. D. (pessoa física)

Representatives

Dyan Finguerra-DuCharme PRYOR CASHMAN LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dermatological pharmaceutical products; medicated skin care preparations; medicated lotions for treating dermatological conditions; medicated creams for treating dermatological conditions

Publications

History of USPTO decisions and trademark events.

34 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/14/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/14/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/13/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/12/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/13/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/25/2023

IUAF

USE AMENDMENT FILED

08/18/2023

EISU

TEAS STATEMENT OF USE RECEIVED

08/18/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/02/2023

EX1G

SOU EXTENSION 1 GRANTED

02/28/2023

EXT1

SOU EXTENSION 1 FILED

02/28/2023

EEXT

SOU TEAS EXTENSION RECEIVED

02/28/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/20/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/26/2022

PUBO

PUBLISHED FOR OPPOSITION

07/26/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/22/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/26/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/26/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/26/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/28/2022

GNRT

NON-FINAL ACTION E-MAILED

03/28/2022

CNRT

NON-FINAL ACTION WRITTEN

03/28/2022

ZZAX

PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU

03/28/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

02/22/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

01/18/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/18/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

01/18/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/18/2022

DOCK

ASSIGNED TO EXAMINER

01/11/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/25/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/24/2021

NWAP

NEW APPLICATION ENTERED

07/29/2021

Continuous trademark protection

Get notified about every new filing that threatens LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.